Synaptotagmin VIII play pivotal roles in its functional engagement in the complex process of synaptic vesicle fusion. Calcium chloride is a prime activator of Synaptotagmin VIII, where the influx of calcium ions (Ca2+) directly binds to the C2 domains of the protein, an action that is fundamental for the mediation of vesicle fusion at the presynaptic terminal. This binding prompts a conformational change in Synaptotagmin VIII, which, in conjunction with SNARE proteins, leads to the fusion of synaptic vesicles with the plasma membrane and subsequent neurotransmitter release. Similarly, phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid located in the plasma membrane, also engages with Synaptotagmin VIII. The interaction between PIP2 and Synaptotagmin VIII facilitates the protein's membrane association, thereby enhancing its role in neurotransmitter release.
Fatty acids such as eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid, oleic acid, linoleic acid, and alpha-linolenic acid, contribute to the regulation of synaptic membrane properties. These fatty acids can be integrated into the membrane, altering its fluidity and curvature, which in turn can support the vesicle fusion mediated by Synaptotagmin VIII. The proper integration and balance of these fatty acids are vital for maintaining the physical state of the membrane, thus optimizing the conditions for Synaptotagmin VIII to facilitate vesicle docking and fusion. Additionally, sphingosine and ceramide, components of the lipid signaling pathway, can modulate the structural integrity of the membrane. They play a role in the organization of lipid microdomains which may enable more efficient binding and function of Synaptotagmin VIII in the exocytotic process. Cholesterol and sphingomyelin, by influencing the membrane's fluidity and domain formation, can also contribute to the optimal environment for Synaptotagmin VIII activation and function. Cholesterol, in particular, by affecting the biophysical properties of the synaptic vesicle membrane, can provide a conducive platform for Synaptotagmin VIII to carry out its critical role in neurotransmission.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium ions (Ca2+) activate Synaptotagmin VIII by binding to its C2 domains, which triggers vesicle fusion in the presence of SNARE proteins. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
Eicosapentaenoic acid (EPA) can integrate into synaptic membranes, altering their physical properties and potentially enhancing the interaction of Synaptotagmin VIII with other membrane components for vesicle fusion. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
Docosahexaenoic acid (DHA) can be incorporated into neuronal membranes, which might enhance membrane fluidity and facilitate Synaptotagmin VIII-mediated vesicle fusion. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
Arachidonic acid can modify the synaptic vesicle membrane composition, potentially increasing the activity of Synaptotagmin VIII in the vesicle docking and fusion processes. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $36.00 $102.00 $569.00 $1173.00 | 10 | |
Oleic acid, by its incorporation into neuronal membranes, may influence membrane fluidity, potentially promoting Synaptotagmin VIII's ability to mediate vesicle fusion. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $33.00 $63.00 $163.00 $275.00 | 4 | |
Linoleic acid may alter membrane properties, which could enhance the function of Synaptotagmin VIII in synaptic vesicle fusion. | ||||||
α-Linolenic Acid | 463-40-1 | sc-205545 sc-205545A | 50 mg 250 mg | $37.00 $113.00 | 2 | |
Alpha-linolenic acid could improve membrane fluidity, which may facilitate the action of Synaptotagmin VIII in exocytotic processes. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $88.00 $190.00 $500.00 $2400.00 $9200.00 $15000.00 | 2 | |
Sphingosine can be involved in the regulation of membrane domains and might support Synaptotagmin VIII in its role in exocytosis by affecting the lipid environment. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Cholesterol is a major component of synaptic vesicle membranes and can influence membrane fluidity and curvature, potentially promoting Synaptotagmin VIII's role in vesicle fusion. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $163.00 $520.00 | 3 | |
Sphingomyelin presence in the plasma membrane can create lipid domains that might enhance the membrane association of Synaptotagmin VIII, facilitating its activation during vesicle fusion. | ||||||